# ILOPROST
> **ANDA214997** · Abbreviated New Drug Application (Generic) · Sponsor: REGCON HOLDINGS · Approved 2026-07-10
## Drug
- **FDA Application Number:** ANDA214997
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ILOPROST
- **Generic name:** Iloprost
- **Active ingredients:** ILOPROST
- **Dosage form:** SOLUTION
- **Route:** INHALATION
- **Marketing status:** Prescription
- **Sponsor:** REGCON HOLDINGS
- **First approval:** 2026-07-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214997)
---
*MORVS · CC0 1.0*